Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. They are increasingly being used in the management of non-psychotic disorders. Antipsychotics are usually effective in relieving symptoms of psychosis in the short term.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Antipsychotics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Antipsychotics market. Detailed analysis of key players, along with key growth strategies adopted by Antipsychotics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Eli Lilly & Co
Allergan
Johnson & Johnson
Glaxo SmithKline
AstraZeneca
Bristol-Myers Squibb
Pfizer
By Type:
First Generation
Second Generation
Third Generation
By End-User:
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Antipsychotics Market
-
1.3 Market Segment by Type
-
1.3.1 USA Antipsychotics Market Size and Growth Rate of First Generation from 2016 to 2027
-
1.3.2 USA Antipsychotics Market Size and Growth Rate of Second Generation from 2016 to 2027
-
1.3.3 USA Antipsychotics Market Size and Growth Rate of Third Generation from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Antipsychotics Market Size and Growth Rate of Schizophrenia from 2016 to 2027
-
1.4.2 USA Antipsychotics Market Size and Growth Rate of Bipolar Disorder from 2016 to 2027
-
1.4.3 USA Antipsychotics Market Size and Growth Rate of Unipolar Depression from 2016 to 2027
-
1.4.4 USA Antipsychotics Market Size and Growth Rate of Dementia from 2016 to 2027
-
1.4.5 USA Antipsychotics Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Antipsychotics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Antipsychotics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Antipsychotics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Antipsychotics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Antipsychotics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Antipsychotics by Major Types
-
3.4.1 Market Size and Growth Rate of First Generation
-
3.4.2 Market Size and Growth Rate of Second Generation
-
3.4.3 Market Size and Growth Rate of Third Generation
4 Segmentation of Antipsychotics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Antipsychotics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Antipsychotics in Schizophrenia
-
4.4.2 Market Size and Growth Rate of Antipsychotics in Bipolar Disorder
-
4.4.3 Market Size and Growth Rate of Antipsychotics in Unipolar Depression
-
4.4.4 Market Size and Growth Rate of Antipsychotics in Dementia
-
4.4.5 Market Size and Growth Rate of Antipsychotics in Others
5 Market Analysis by Regions
-
5.1 USA Antipsychotics Production Analysis by Regions
-
5.2 USA Antipsychotics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Antipsychotics Landscape Analysis
-
6.1 West USA Antipsychotics Landscape Analysis by Major Types
-
6.2 West USA Antipsychotics Landscape Analysis by Major End-Users
7 South USA Antipsychotics Landscape Analysis
-
7.1 South USA Antipsychotics Landscape Analysis by Major Types
-
7.2 South USA Antipsychotics Landscape Analysis by Major End-Users
8 Middle West USA Antipsychotics Landscape Analysis
-
8.1 Middle West USA Antipsychotics Landscape Analysis by Major Types
-
8.2 Middle West USA Antipsychotics Landscape Analysis by Major End-Users
9 Northeast USA Antipsychotics Landscape Analysis
-
9.1 Northeast USA Antipsychotics Landscape Analysis by Major Types
-
9.2 Northeast USA Antipsychotics Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Eli Lilly & Co
-
10.1.1 Eli Lilly & Co Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Allergan
-
10.2.1 Allergan Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Johnson & Johnson
-
10.3.1 Johnson & Johnson Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Glaxo SmithKline
-
10.4.1 Glaxo SmithKline Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 AstraZeneca
-
10.5.1 AstraZeneca Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Bristol-Myers Squibb
-
10.6.1 Bristol-Myers Squibb Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Pfizer
-
10.7.1 Pfizer Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Antipsychotics Market Size and Growth Rate of First Generation from 2016 to 2027
-
Figure USA Antipsychotics Market Size and Growth Rate of Second Generation from 2016 to 2027
-
Figure USA Antipsychotics Market Size and Growth Rate of Third Generation from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Antipsychotics Market Size and Growth Rate of Schizophrenia from 2016 to 2027
-
Figure USA Antipsychotics Market Size and Growth Rate of Bipolar Disorder from 2016 to 2027
-
Figure USA Antipsychotics Market Size and Growth Rate of Unipolar Depression from 2016 to 2027
-
Figure USA Antipsychotics Market Size and Growth Rate of Dementia from 2016 to 2027
-
Figure USA Antipsychotics Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Antipsychotics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Antipsychotics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Antipsychotics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Antipsychotics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Antipsychotics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Antipsychotics
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Antipsychotics by Different Types from 2016 to 2027
-
Table Consumption Share of Antipsychotics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of First Generation
-
Figure Market Size and Growth Rate of Second Generation
-
Figure Market Size and Growth Rate of Third Generation
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Antipsychotics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Antipsychotics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Schizophrenia
-
Figure Market Size and Growth Rate of Bipolar Disorder
-
Figure Market Size and Growth Rate of Unipolar Depression
-
Figure Market Size and Growth Rate of Dementia
-
Figure Market Size and Growth Rate of Others
-
Table USA Antipsychotics Production by Regions
-
Table USA Antipsychotics Production Share by Regions
-
Figure USA Antipsychotics Production Share by Regions in 2016
-
Figure USA Antipsychotics Production Share by Regions in 2021
-
Figure USA Antipsychotics Production Share by Regions in 2027
-
Table USA Antipsychotics Consumption by Regions
-
Table USA Antipsychotics Consumption Share by Regions
-
Figure USA Antipsychotics Consumption Share by Regions in 2016
-
Figure USA Antipsychotics Consumption Share by Regions in 2021
-
Figure USA Antipsychotics Consumption Share by Regions in 2027
-
Table West USA Antipsychotics Consumption by Types from 2016 to 2027
-
Table West USA Antipsychotics Consumption Share by Types from 2016 to 2027
-
Figure West USA Antipsychotics Consumption Share by Types in 2016
-
Figure West USA Antipsychotics Consumption Share by Types in 2021
-
Figure West USA Antipsychotics Consumption Share by Types in 2027
-
Table West USA Antipsychotics Consumption by End-Users from 2016 to 2027
-
Table West USA Antipsychotics Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Antipsychotics Consumption Share by End-Users in 2016
-
Figure West USA Antipsychotics Consumption Share by End-Users in 2021
-
Figure West USA Antipsychotics Consumption Share by End-Users in 2027
-
Table South USA Antipsychotics Consumption by Types from 2016 to 2027
-
Table South USA Antipsychotics Consumption Share by Types from 2016 to 2027
-
Figure South USA Antipsychotics Consumption Share by Types in 2016
-
Figure South USA Antipsychotics Consumption Share by Types in 2021
-
Figure South USA Antipsychotics Consumption Share by Types in 2027
-
Table South USA Antipsychotics Consumption by End-Users from 2016 to 2027
-
Table South USA Antipsychotics Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Antipsychotics Consumption Share by End-Users in 2016
-
Figure South USA Antipsychotics Consumption Share by End-Users in 2021
-
Figure South USA Antipsychotics Consumption Share by End-Users in 2027
-
Table Middle West USA Antipsychotics Consumption by Types from 2016 to 2027
-
Table Middle West USA Antipsychotics Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Antipsychotics Consumption Share by Types in 2016
-
Figure Middle West USA Antipsychotics Consumption Share by Types in 2021
-
Figure Middle West USA Antipsychotics Consumption Share by Types in 2027
-
Table Middle West USA Antipsychotics Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Antipsychotics Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Antipsychotics Consumption Share by End-Users in 2016
-
Figure Middle West USA Antipsychotics Consumption Share by End-Users in 2021
-
Figure Middle West USA Antipsychotics Consumption Share by End-Users in 2027
-
Table Northeast USA Antipsychotics Consumption by Types from 2016 to 2027
-
Table Northeast USA Antipsychotics Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Antipsychotics Consumption Share by Types in 2016
-
Figure Northeast USA Antipsychotics Consumption Share by Types in 2021
-
Figure Northeast USA Antipsychotics Consumption Share by Types in 2027
-
Table Northeast USA Antipsychotics Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Antipsychotics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Antipsychotics Consumption Share by End-Users in 2016
-
Figure Northeast USA Antipsychotics Consumption Share by End-Users in 2021
-
Figure Northeast USA Antipsychotics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Eli Lilly & Co
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly & Co
-
Figure Sales and Growth Rate Analysis of Eli Lilly & Co
-
Figure Revenue and Market Share Analysis of Eli Lilly & Co
-
Table Product and Service Introduction of Eli Lilly & Co
-
Table Company Profile and Development Status of Allergan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
-
Figure Sales and Growth Rate Analysis of Allergan
-
Figure Revenue and Market Share Analysis of Allergan
-
Table Product and Service Introduction of Allergan
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Glaxo SmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glaxo SmithKline
-
Figure Sales and Growth Rate Analysis of Glaxo SmithKline
-
Figure Revenue and Market Share Analysis of Glaxo SmithKline
-
Table Product and Service Introduction of Glaxo SmithKline
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
